Validation of the procedure for determination of amino acids composition of glatiramer acetate by C-13 NMR spectroscopy

The article describes validation of the procedure for determination of amino acids composition of glatiramer acetate by C-13 NMR spectroscopy. The procedure makes it possible to determine the molar ratio of amino acids present in glatiramer acetate with no need for a reference standard. The authors evaluated the accuracy, linearity, repeatability, intermediate precision and specificity of the validated procedure. The analysis of extraction factors for L-Glu, L-Ala, L-Tyr и L-Lys helped to calculate the systematic errors, standard deviations, confidence intervals, variation coefficients, confidence intervals, Fisher’s test and Student’s t-test for the results of amino acids molar ratio determination. It was shown that the obtained statistical data satisfy the acceptance criteria for validation parameters described in the national and foreign quality standards.

глатирамера ацетат, метод¹³C ЯМР-спектроскопии, аминокислотный состав, валидация аналитической методики, линейность, правильность, сходимость, прецизионность, glatiramer acetate, C-13 NMR spectroscopy, amino acids composition, analytical procedure validation, linearity, accuracy, repeatability, precision

1. Shmidt TE. Glatiramer acetate is a first-line dual-action drug for the treatment of relapsing-remitting multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics 2016; 8(4): 77–80 (in Russian).

2. Kuz’mina NE, Moiseev SV, Krylov VI, Kutin AA, Yashkir VA, Merkulov VA. Development of the procedure for determination of amino acids composition of glatiramer acetate by NMR spectroscopy. Pharmaceutical Chemistry Journal 2017; 51(3); 45–8 (in Russian).

3. Kuz’mina NE, Moiseev SV, Yashkir VA, Osintseva EV. The possibility of the nuclear magnetic resonance methods using for reference standards certification. Reference materials 2014; (2): 19–25 (in Russian).

4. Malz F, Jancke H. Validation of quantitative nuclear magnetic resonance. J Pharm Biomed Anal. 2005; 38(5): 813–23.

5. Yurgel NV, ed. Guideline for Analytical Methods Validation for Drugs. Methodological Recommendations. Moscow: Sport i Kul’tura-2000; 2007 (in Russian).

6. Beregovykh VV, ed. Validation of analytical methods by drug manufacturers. Guiding principles for drug manufacturers. Moscow: Litterra; 2008 (in Russian).

7. General monograph 1.1.0012.15. Validation of analytical procedures. State Pharmacopoeia of the Russian Federation. 13th ed. V. I. Moscow; 2015. Available from: http://femb.ru/feml (in Russian).

8. Nuclear Magnetic Resonance. United States Pharmacopoeia. National Formulary USP 40—NF 35. Rockville; 2016.

9. RMG 61–2003 GSI. Accuracy, trueness and precision of quantitative chemical analysis. Methods of evaluation. Moscow: Izdatelstvo standartov; 2004 (in Russian).

10. State Standard R ISO 5725-2–2002. Accuracy (trueness and precision) of measurement methods and results. Part 2. Basic method for determination of repeatability and reproducibility of a standard method of measurement. Moscow: Izdatelstvo standartov; 2002 (in Russian).

11. Dolittski B-Z. Method of preparation of polypeptide mixtures using purified hydrobromic acid. Patent RF, ¹ 2388764 C2; 2010 (in Russian).